Indication
Eosinophilic asthma
5 clinical trials
7 products
Clinical trial
A Real World Multicenter 48 Week Prospective Cohort Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab in Routine Care Settings in GreeceStatus: Recruiting, Estimated PCD: 2025-06-30
Product
CohortClinical trial
SHAMAL: A Multicentre, Randomised, Open-Label, Parallel-Group, Active-Controlled, Phase IV Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With BenralizumabStatus: Completed, Estimated PCD: 2023-01-31
Product
Ventolin®Product
Fasenra®Product
Symbicort®Clinical trial
A Multicenter, Single-group Phase II Clinical Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of Multiple Subcutaneous Injections of SHR-1703 in Eosinophilic Asthma PatientsStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Product
SHR-1703Clinical trial
Evaluation of Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis With Nasal Polyps and Comorbid Severe Eosinophilic Asthma: an Integrative Multi-omics Approach to Assess Biomarker Signatures of Responsive Disease EndotypesStatus: Recruiting, Estimated PCD: 2025-09-03
Product
MepolizumabClinical trial
STEP: A Prospective, Interventional, Multicenter, Single-Arm Phase 3b Study to Evaluate the Step-Down of Maintenance Therapy in Patients With Severe Eosinophilic Asthma Treated With BenralizumabStatus: Recruiting, Estimated PCD: 2025-10-31
Product
Benralizumab